Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A southwest oncology group study
โ Scribed by Joseph D. McCcracken; Lance Heilbrun; Joel White; Richard Reed; Michael Samson; Joseph H. Saiers; Ronald Stephens; W. J. Stuckey; John Bickers; Robert Livingston
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 539 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The Southwest Oncology Group performed a randomized study comparing combination chemotherapy alone versus combination chemotherapy plus BCG versus DTIC plus BCG in the treatment of disseminated malignant melanoma. A 31% response rate was noted with combination chemotherapy alone, a 27%
## BACKGROUND. The combined use of cisplatin and carboplatin chemotherapy offers a unique means of platinum dose intensification. Response rates using either of these agents in combination with etoposide are comparable. In a Phase II trial, the authors investigated the combination of cisplatin and